Alain Prost Injured in Home Raid Security Concerns for HighProfile Figures Analysts Suggest MegaIPOs From SpaceX and OpenAI May Signal Market Peak as Record Listings Loom Government Plans Up to 2 LIC Stake Sale Potentially Raising Rs 10000 Crore Bloom Energy Secures 26B Deal Signaling Potential Growth Amazon Faces Allegations Over Millions in Revenue from NowIllegal Policy AIDriven Layoffs Market Reaction May Not Be Positive Reynolds Consumer Products Q1 2026 Earnings EPS Surprise Beats Estimates Amid Quiet Revenue Disclosure USAC Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds KLAR Q1 2026 Earnings Significant EPS Beat as Losses Narrow Sharply BAC Q1 2026 Earnings Bank of America Beats on Strong Expense Control and Steady NII AEE Q1 2026 Earnings EPS Beats Estimates as Utility Gains on Operational Efficiency NBHC Q1 2026 Earnings EPS Misses Estimates as Shares Edge Higher Flotek Industries FTK Pushes Higher Testing Key Resistance Levels ABVC BioPharma Inc ABVC Holds Near Support Showing Cautious Recovery Potential Strawberry Fields REIT STRW Modestly Advances as It Approaches Key Resistance Level Ferrari RACE Faces Sharp Pullback Key Support Levels in Focus DarioHealth Holds Steady at 77 Consolidation Near Resistance in a Flat Session Retail Investors Gain Unprecedented Access to Potential SpaceX IPO Through Major Brokerages WD Q1 2026 Earnings EPS Surges Past Estimates with 62 Surprise AvalonBay Communities Holds Steady Near Resistance AVB Gains 084 as REIT Sector Shows Mixed Signals XENE Q1 2026 Earnings Narrower Net Loss Highlights Clinical and Strategic Progress Harrow Inc HROW Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges BranchOut Food Inc BOF Q1 2026 Earnings Wider Loss Reported as Revenue Remains Undisclosed STG Q3 2025 Earnings Reported EPS of 932 Stock Declines 95 Amid Limited Disclosures Hut 8 Corp Q3 2024 Earnings EPS beats estimates as company navigates Bitcoin mining headwinds GEOS Q1 2026 Earnings Adjusted Loss of 086 Per Share Stock Declines LCTX Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Reports No Revenue